Chowdhury SF - Search Results

1

Management of Hemoglobin Disorders During the COVID-19 Pandemic.

Chowdhury SF, Anwar S. Chowdhury SF, et al. Front Med (Lausanne). 2020 Jun 9;7:306. doi: 10.3389/fmed.2020.00306. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32582745 Free PMC article. Review.

2

Research and Management of Rare Diseases in the COVID-19 Pandemic Era: Challenges and Countermeasures.

Chowdhury SF, Sium SMA, Anwar S. Chowdhury SF, et al. Front Public Health. 2021 Apr 15;9:640282. doi: 10.3389/fpubh.2021.640282. eCollection 2021. Front Public Health. 2021. PMID: 33937170 Free PMC article. Review.

3

Characterizing domain-specific open educational resources by linking ISCB Communities of Special Interest to Wikipedia.

Kilpatrick AM, Rahman F, Anjum A, Shome S, Andalib KMS, Banik S, Chowdhury SF, Coombe P, Astroz YC, Douglas JM, Eranti P, Kiran AD, Kumar S, Lim H, Lorenzi V, Lubiana T, Mahmud S, Puche R, Rybarczyk A, Al Sium SM, Twesigomwe D, Zok T, Orengo CA, Friedberg I, Kelso JF, Welch L. Kilpatrick AM, et al. Among authors: chowdhury sf. Bioinformatics. 2022 Jun 24;38(Suppl 1):i19-i27. doi: 10.1093/bioinformatics/btac236. Bioinformatics. 2022. PMID: 35758800 Free PMC article.

4

Evaluation of Serum Glial Cell Line-derived Neurotrophic Factor in Bangladeshi Major Depressive Disorder Patients.

Das R, Emon MPZ, Chowdhury SF, Huque S, Zahan T, Islam MR. Das R, et al. Among authors: chowdhury sf. Cureus. 2019 Nov 6;11(11):e6081. doi: 10.7759/cureus.6081. Cureus. 2019. PMID: 31853432 Free PMC article.

5

Characterization of the NPC1L1 gene and proteome from an exceptional responder to ezetimibe.

Schweitzer M, Makhoul S, Paliouras M, Beitel LK, Gottlieb B, Trifiro M, Chowdhury SF, Zaman NM, Wang E, Davis H, Chalifour LE. Schweitzer M, et al. Among authors: chowdhury sf. Atherosclerosis. 2016 Mar;246:78-86. doi: 10.1016/j.atherosclerosis.2015.12.032. Epub 2015 Dec 24. Atherosclerosis. 2016. PMID: 26761771

6

Toward 300 mm wafer-scalable high-performance polycrystalline chemical vapor deposited graphene transistors.

Rahimi S, Tao L, Chowdhury SF, Park S, Jouvray A, Buttress S, Rupesinghe N, Teo K, Akinwande D. Rahimi S, et al. Among authors: chowdhury sf. ACS Nano. 2014 Oct 28;8(10):10471-9. doi: 10.1021/nn5038493. Epub 2014 Sep 15. ACS Nano. 2014. PMID: 25198884

7

Transformation of the electrical characteristics of graphene field-effect transistors with fluoropolymer.

Ha TJ, Lee J, Chowdhury SF, Akinwande D, Rossky PJ, Dodabalapur A. Ha TJ, et al. Among authors: chowdhury sf. ACS Appl Mater Interfaces. 2013 Jan;5(1):16-20. doi: 10.1021/am3025323. Epub 2012 Dec 27. ACS Appl Mater Interfaces. 2013. PMID: 23252452

8

Handheld impedance biosensor system using engineered proteinaceous receptors.

Ghafar-Zadeh E, Chowdhury SF, Aliakbar A, Chodavarapu V, Lumbroso R, Beitel LK, Sawan M, Trifiro M. Ghafar-Zadeh E, et al. Among authors: chowdhury sf. Biomed Microdevices. 2010 Dec;12(6):967-75. doi: 10.1007/s10544-010-9451-0. Biomed Microdevices. 2010. PMID: 20652414

9

Medication taking behavior of students attending a private university in Bangladesh.

Chowdhury N, Matin F, Chowdhury SF. Chowdhury N, et al. Among authors: chowdhury sf. Int J Adolesc Med Health. 2009 Jul-Sep;21(3):361-70. doi: 10.1515/ijamh.2009.21.3.361. Int J Adolesc Med Health. 2009. PMID: 20014639

10

A combined crystallographic and molecular dynamics study of cathepsin L retrobinding inhibitors.

Shenoy RT, Chowdhury SF, Kumar S, Joseph L, Purisima EO, Sivaraman J. Shenoy RT, et al. Among authors: chowdhury sf. J Med Chem. 2009 Oct 22;52(20):6335-46. doi: 10.1021/jm900596y. J Med Chem. 2009. PMID: 19761244

11

An investigation into CAG repeat length variation and N/C terminal interactions in the T877A mutant androgen receptor found in prostate cancer.

Southwell J, Chowdhury SF, Gottlieb B, Beitel LK, Lumbroso R, Purisima EO, Trifiro M. Southwell J, et al. Among authors: chowdhury sf. J Steroid Biochem Mol Biol. 2008 Jul;111(1-2):138-46. doi: 10.1016/j.jsbmb.2008.04.009. Epub 2008 Jun 20. J Steroid Biochem Mol Biol. 2008. PMID: 18619542

12

Exploring inhibitor binding at the S' subsites of cathepsin L.

Chowdhury SF, Joseph L, Kumar S, Tulsidas SR, Bhat S, Ziomek E, Ménard R, Sivaraman J, Purisima EO. Chowdhury SF, et al. J Med Chem. 2008 Mar 13;51(5):1361-8. doi: 10.1021/jm701190v. Epub 2008 Feb 16. J Med Chem. 2008. PMID: 18278855

13

Solvated interaction energy (SIE) for scoring protein-ligand binding affinities. 1. Exploring the parameter space.

Naïm M, Bhat S, Rankin KN, Dennis S, Chowdhury SF, Siddiqi I, Drabik P, Sulea T, Bayly CI, Jakalian A, Purisima EO. Naïm M, et al. Among authors: chowdhury sf. J Chem Inf Model. 2007 Jan-Feb;47(1):122-33. doi: 10.1021/ci600406v. J Chem Inf Model. 2007. PMID: 17238257

14

Effect of limited solid-state glycation on the conformation of lysozyme by ESI-MSMS peptide mapping and molecular modeling.

Yeboah FK, Alli I, Yaylayan VA, Yasuo K, Chowdhury SF, Purisima EO. Yeboah FK, et al. Among authors: chowdhury sf. Bioconjug Chem. 2004 Jan-Feb;15(1):27-34. doi: 10.1021/bc034083v. Bioconjug Chem. 2004. PMID: 14733580

15

Synthesis and testing of 5-benzyl-2,4-diaminopyrimidines as potential inhibitors of leishmanial and trypanosomal dihydrofolate reductase.

Chowdhury SF, Guerrero RH, Brun R, Ruiz-Perez LM, Pacanowska DG, Gilbert IH. Chowdhury SF, et al. J Enzyme Inhib Med Chem. 2002 Oct;17(5):293-302. doi: 10.1080/1475636021000059083. J Enzyme Inhib Med Chem. 2002. PMID: 12683746

16

Design of noncovalent inhibitors of human cathepsin L. From the 96-residue proregion to optimized tripeptides.

Chowdhury SF, Sivaraman J, Wang J, Devanathan G, Lachance P, Qi H, Ménard R, Lefebvre J, Konishi Y, Cygler M, Sulea T, Purisima EO. Chowdhury SF, et al. J Med Chem. 2002 Nov 21;45(24):5321-9. doi: 10.1021/jm020238t. J Med Chem. 2002. PMID: 12431059

17

Novel inhibitors of Trypanosoma cruzi dihydrofolate reductase.

Zuccotto F, Zvelebil M, Brun R, Chowdhury SF, Di Lucrezia R, Leal I, Maes L, Ruiz-Perez LM, Gonzalez Pacanowska D, Gilbert IH. Zuccotto F, et al. Among authors: chowdhury sf. Eur J Med Chem. 2001 May;36(5):395-405. doi: 10.1016/s0223-5234(01)01235-1. Eur J Med Chem. 2001. PMID: 11451529

18

Novel inhibitors of Leishmanial dihydrofolate reductase.

Chowdhury SF, Di Lucrezia R, Guerrero RH, Brun R, Goodman J, Ruiz-Perez LM, Pacanowska DG, Gilbert IH. Chowdhury SF, et al. Bioorg Med Chem Lett. 2001 Apr 23;11(8):977-80. doi: 10.1016/s0960-894x(01)00089-0. Bioorg Med Chem Lett. 2001. PMID: 11327604

19

Design, synthesis, and evaluation of inhibitors of trypanosomal and leishmanial dihydrofolate reductase.

Chowdhury SF, Villamor VB, Guerrero RH, Leal I, Brun R, Croft SL, Goodman JM, Maes L, Ruiz-Perez LM, Pacanowska DG, Gilbert IH. Chowdhury SF, et al. J Med Chem. 1999 Oct 21;42(21):4300-12. doi: 10.1021/jm981130+. J Med Chem. 1999. PMID: 10543874

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results